Director, Market Access Lead

argenx • Boston, MA

3d

About The Position

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.
We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.
For the expansion of our Global Market Access Team, argenx is looking for a Market Access MG Lead.
PURPOSE OF THE FUNCTION
It is an exciting time of growth for argenx as we strive to achieve our VISION 2030. Vision 2030 is our long-term commitment to transform the treatment of autoimmune diseases by strengthening its leadership in neonatal Fc receptor (FcRn) biology, investing in its continuous pipeline of differentiated antibody candidates, and scaling in a disciplined way to ensure innovation remains core to the argenx mission. ‘Vision 2030’ includes the following goals: 50,000 patients globally on treatment with an argenx medicine, 10 labeled indications across all approved assets, including VYVGART and potentially empasiprubart and ARGX-119 and five new molecules in Phase 3 development.
The Market Access MG Lead will be responsible for the leading strategic access for the therapeutic area of Myasthenia Gravis, with key focus on next indication expansion global launches, development of next generation FcRn products and overall life-cycle management in a situation of rising competitors’ pressure. The argenx Global Market Access team works across all countries, including US, Developed Markets and Japan, and in close collaboration with other functions and with local country teams.

Requirements

• Have experience and deep understanding of payer needs, decision-making approaches, strategies, and country reimbursement stakeholders and influencers in US and/or key EU markets
• Experience in developing global and regional pricing and market access strategies and research
• Experience working with clinical development teams
• Experience working within launch and commercialization teams for therapies in the orphan and rare disease space
• Experience effectively managing external agency partners, and collaborating with cross-functional teams and internal/external stakeholders to effectively implement strategies and programs
• Highly organized, with demonstrated ability to effectively manage multiple priorities under pressure
• Ability to grasp highly technical concepts and to work within a deeply scientific environment; Exceptional learning agility, demonstrated by advancement in prior roles/companies
• Ability to work collaboratively and effectively together within cross-functional teams and networks
• Demonstrated communication skills, within a multi-cultural and multi-lingual global environment
• Is agile and demonstrates adaptability, comfort with ambiguity, trust-building, and resilience
• Drives toward outcomes
• Ambitious, inquisitive naturally, a quick study, with demonstrated eagerness to continuously learn, self-improve and develop. This includes being comfortable giving and receiving feedback in a diverse environment.
• Passionate and prepared to lead and contribute to our culture, which is driven by our corporate values of co-creation, innovation, empowerment, excellence, and humility.
• 7+ years of relevant industry experience in biotech/pharma.
• 5+ years Market Access & Pricing experience specifically involving specialty drug launches in US or Europe
• Strong leadership and team management skills, with the ability to influence and align cross-functional teams.
• Strategic and critical thinking and problem-solving skills. Ability to navigate ambiguity and complexity and succinctly articulate complex problems and possible solutions
• Fluent English language required

Nice To Haves

• Master’s degree in Business Administration, Health Economics, Life Sciences, or a related field. Ph.D. or MBA preferred.

Responsibilities

• Determines early market access potential, pricing and strategy for pipeline indications and assets including indication sequencing, TPP, and TPL
• Work with Indication Development Teams (IDTs) to optimize trial designs so they reflect payer requirements, by incorporating feedback and needs from regional Access
• Coordinate Early Scientific Advice from key HTA Agencies and conduct gap analyses with external consultants
• Work with Indication Commercial Teams (ICTs) to align Access and Commercial positioning, pricing and strategy
• Assess unmet need, outline payer value proposition, assess P&R / HTA landscape and product outlook
• Inform development of global pricing strategy and policy
• Test payer value messages, pricing expectations, and value proposition via Advisory Boards and research with payers / HTA
• Develop core value dossier and objection handler
• Develop innovative access strategies on a global and regional level incl. early access, and evaluate implications for launch (go, no-go risk mitigation and scenario planning)
• Build out and validate contracting options and G2N assumptions
• Partner with HEOR and Regional Access to optimize the evidence generation plan, identify epidemiology and the unmet medical need
• Inform the development of health economic and outcomes analyses (CEA, BIA, burden of disease, etc.) required for access, working in collaboration with internal cross-functional teams
• Facilitate launch readiness workshops with regional and local Market Access and other functions

Benefits

• This job is eligible to participate in our short-term and long-term incentives program.

What This Job Offers

• Job Type: Full-time
• Career Level: Director